NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $10,000 | -64.3% | 283 | -65.9% | 0.00% | -100.0% |
Q1 2019 | $28,000 | -91.5% | 830 | -91.8% | 0.00% | -85.7% |
Q4 2018 | $331,000 | -47.7% | 10,074 | -3.1% | 0.01% | -41.7% |
Q3 2018 | $633,000 | +3416.7% | 10,394 | +2664.4% | 0.01% | – |
Q2 2018 | $18,000 | -70.0% | 376 | -32.6% | 0.00% | -100.0% |
Q1 2018 | $60,000 | -99.2% | 558 | -99.6% | 0.00% | -99.5% |
Q4 2017 | $7,739,000 | +246.4% | 129,592 | +39.3% | 0.20% | +268.5% |
Q3 2017 | $2,234,000 | +21.9% | 93,064 | -0.7% | 0.05% | +12.5% |
Q2 2017 | $1,832,000 | +289.0% | 93,694 | +366.9% | 0.05% | +300.0% |
Q1 2017 | $471,000 | +93.8% | 20,066 | +1.2% | 0.01% | +71.4% |
Q4 2016 | $243,000 | -18.7% | 19,827 | +14.0% | 0.01% | -46.2% |
Q3 2016 | $299,000 | +21.5% | 17,385 | +0.6% | 0.01% | 0.0% |
Q2 2016 | $246,000 | +7.9% | 17,281 | +4.0% | 0.01% | +8.3% |
Q1 2016 | $228,000 | -24.3% | 16,610 | -7.3% | 0.01% | -7.7% |
Q4 2015 | $301,000 | +63.6% | 17,912 | +7.0% | 0.01% | +62.5% |
Q3 2015 | $184,000 | -3.2% | 16,743 | +10.4% | 0.01% | 0.0% |
Q2 2015 | $190,000 | – | 15,166 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |